Clinical Trials
42 trialsTowards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance
Fondazione IRCCS Policlinico San Matteo di Pavia
ALPS
Fondazione IRCCS Policlinico San Matteo di Pavia
ReAL
Fondazione IRCCS Policlinico San Matteo di Pavia
EUREKA
Fondazione IRCCS Policlinico San Matteo di Pavia
ProDigALIty
Fondazione IRCCS Policlinico San Matteo di Pavia
ITA-WebNet
Fondazione IRCCS Policlinico San Matteo di Pavia
B-SCR-MM
Ohio State University Comprehensive Cancer Center
MED-hATTR
The Cleveland Clinic
Rapid dFLC Response Predict CHR in AL Amyloidosis
Peking University People's Hospital
GlycAL
Fondazione IRCCS Policlinico San Matteo di Pavia
BE.Amycon Biobank & Data Registry UZ Leuven
Universitaire Ziekenhuizen KU Leuven
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
City of Hope Medical Center
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Boston Medical Center
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
EAR
University Hospital, Essen
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Tufts Medical Center
AL-CA
Beijing Anzhen Hospital
Registry of Older Patients With Cancer
UNC Lineberger Comprehensive Cancer Center
ICAR
Leiden University Medical Center
NIMMS
St. Olavs Hospital
Screening to Improve Survival in AL Amyloidosis
Tufts Medical Center
DOrianT
Takeda
Autologous Stem Cell Transplantation for Patients With AL Amyloidosis
Nanjing University School of Medicine
Amyloidosis Incidence in High-Risk Cardiac Device Patients
Midwest Heart & Vascular Specialists
RaDaR
UK Kidney Association
CARS
Cedars-Sinai Medical Center
The Diagnostic Value of Hybrid PET/MR for Systemic Amyloidosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe
European Myeloma Network B.V.
A Registry of Chinese AL Amyloidosis Patients Treated With Subcutaneous or Intravenous Daratumumab
Peking Union Medical College Hospital
CAST
The Cleveland Clinic
ALF
The Cleveland Clinic
Collecting and Storing Blood Samples From Patients With Cancer
Rutgers, The State University of New Jersey
MRD
Boston Medical Center
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis
Tufts Medical Center
Quality of Life (QOL) Registry for Patients With AL Amyloidosis
Prothena Biosciences Ltd.
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
European Organisation for Research and Treatment of Cancer - EORTC
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Vanderbilt University Medical Center
Allo SCT in Amyloidosis Non-interventional Study
European Society for Blood and Marrow Transplantation
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
Rutgers, The State University of New Jersey
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
SWOG Cancer Research Network
S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
SWOG Cancer Research Network
Studying Fentanyl in Patients With Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins